As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.

The moves were largely prompted by two pieces of research showing that CRQC (cryptographically relevant quantum ...

Karpathy proposes something simpler and more loosely, messily elegant than the typical enterprise solution of a vector ...

UF scientist develops safer gene therapy restoring vision in children with rare inherited eye diseases; pivotal trials begin ...

Researchers hijacked Claude, Gemini, and Copilot AI agents via prompt injection to steal API keys and tokens. All three ...

XTrace is a memory infrastructure that treats the deliverables your team produces with AI as something worth remembering. Not ...

From cost and performance specs to advanced capabilities and quirks, answers to these questions will help you determine the ...

A routine inspection into Afbi’s operations identified biosecurity shortcomings ...

Twenty years of “think before you click,” and phishing is still the number one attack vector in enterprise security. Every ...

Oligo Security, the runtime security company, today announced Runtime Exploit Blocking, a new capability that stops exploit ...

Payments infrastructure is not a static system. It is a living network of interdependencies — between liquidity pools, ...

Processor architectures are evolving faster than ever, but they still lag the pace of AI development. Chip architects must ...